Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1
Author(s) -
Sofiane Ouerd,
Noureddine Idris-Khodja,
Michelle Trindade,
Nathanne S. Ferreira,
Olga Berillo,
Suellen C Coelho,
Mário Fritsch Neves,
Karin JandeleitDahm,
Pierre Paradis,
Ernesto L. Schiffrin
Publication year - 2020
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvaa168
Subject(s) - nox4 , apolipoprotein e , endocrinology , medicine , nadph oxidase , knockout mouse , oxidative stress , nox1 , streptozotocin , endothelium , inflammation , diabetes mellitus , biology , receptor , disease
NADPH oxidase (NOX) 1 but not NOX4-dependent oxidative stress plays a role in diabetic vascular disease, including atherosclerosis. Endothelin (ET)-1 has been implicated in diabetes-induced vascular complications. We showed that crossing mice overexpressing human ET-1 selectively in endothelium (eET-1) with apolipoprotein E knockout (Apoe-/-) mice enhanced high-fat diet-induced atherosclerosis in part by increasing oxidative stress. We tested the hypothesis that ET-1 overexpression in the endothelium would worsen atherosclerosis in type 1 diabetes through a mechanism involving NOX1 but not NOX4.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom